Lv4
430 积分 2024-04-25 加入
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
5天前
已完结
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
13天前
已完结
Depemokimab in chronic rhinosinusitis with nasal polyps: A turning point or a missed opportunity?
2个月前
已关闭
The global burden of COPD: epidemiology and effect of prevention strategies
3个月前
已完结
The global burden of COPD: epidemiology and effect of prevention strategies
3个月前
已完结
Type 2 airway inflammation in COPD
3个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
3个月前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
3个月前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
3个月前
已完结
An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition
4个月前
已完结
皖公网安备34019202002308
